ArticleTechnology in cancer research & treatment

β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939.

Sheikh Mohammad Umar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.